Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer
No event-free survival benefit with atezolizumab versus placebo in phase III trial
Stay updated with breaking news from Robertl Ferris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
No event-free survival benefit with atezolizumab versus placebo in phase III trial
Associate Director for Basic Cancer Research job in Pittsburgh, Pennsylvania with UPMC Hillman Cancer Center UPMC - Cancer Pavilion. Apply Today.
Associate Director for Translational Research job in Pittsburgh, Pennsylvania with UPMC Hillman Cancer Center UPMC - Cancer Pavilion. Apply Today.
PITTSBURGH--(BUSINESS WIRE)--#CRS--CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it has initiated recruitment and will enroll its first patient at UPMC Hillman Cancer Center, in the Phase 1b/2a clinical trial...
/PRNewswire/ -- Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of...